Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04007770 · ClinicalTrials.gov registry record · Phase 2
Acupuncture Pilot Study for Cancer-related Cognitive Function
A Phase 2 study of Gynecologic Cancer and Stage II Breast Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- Phase 2
- Development phase
- 48
- Enrollment target
- 6
- Study locations
NCT04007770 is a Phase 2 study of Gynecologic Cancer and Stage II Breast Cancer that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 48 participants, below the 764-participant average among 55 other Gynecologic Cancer trials with a reported enrollment target (94% lower). The trial reports 6 study locations across 2 states.
The verdict
NCT04007770, a Phase 2 study of Gynecologic Cancer and Stage II Breast Cancer, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 48 participants
- Enrollment target
- 6
- Study locations
Study Summary
This study is being done to explore whether acupuncture can improve cognitive difficulties in patients diagnosed with cancer.
Conditions Studied
Interventions
- OTHER Acupuncture
- OTHER Sham Acupuncture
- OTHER 16 week waiting period + optional Acupuncture
Study Locations (6)
New Jersey
- Memorial Sloan Kettering Basking Ridge - Basking Ridge
- Memorial Sloan Kettering Monmouth - Middletown
- Memorial Sloan Kettering Bergen - Montvale
New York
- Memorial Sloan Kettering Commack - Commack
- Memorial Sloan Kettering Cancer Center - New York
- Memorial Sloan Kettering Nassau - Uniondale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2019-07-01 |
| Est. Completion | 2026-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04007770
The ClinicalTrials.gov registry entry for NCT04007770 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 764-participant average among 55 other Gynecologic Cancer trials with a reported enrollment target (94% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Gynecologic Cancer appearing as the primary indexed condition, and to 3 interventions - of which Acupuncture is the first listed.
NCT04007770 reports 6 study locations spanning 2 distinct geographic areas - top geographies include New Jersey, New York.
Frequently Asked Questions
What is clinical trial NCT04007770 about?
NCT04007770 is a clinical study titled "Acupuncture Pilot Study for Cancer-related Cognitive Function". This study is being done to explore whether acupuncture can improve cognitive difficulties in patients diagnosed with cancer.
What is the current status of trial NCT04007770?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 48 participants. The study started on 2019-07-01. Estimated completion is 2026-07.
What conditions does trial NCT04007770 study?
This clinical trial studies the following conditions: Gynecologic Cancer, Stage II Breast Cancer, Stage III Breast Cancer, Stage I Breast Cancer, Stage III Colorectal Cancer.
What interventions are being tested in trial NCT04007770?
The interventions under investigation include: Acupuncture (OTHER), Sham Acupuncture (OTHER), 16 week waiting period + optional Acupuncture (OTHER).
Who is sponsoring clinical trial NCT04007770?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04007770 being conducted?
This trial has 6 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gynecologic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
RECRUITING · Phase 2
-
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
RECRUITING · Phase 2
-
The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers (Guarana Fatigue)
RECRUITING · Phase 2
-
Clinical Investigation of the Effects of Semiconductor Embedded Therapeutic Garments on Cancer-related Cognitive Impairment in Breast and Gynecological Cancer Patients
RECRUITING · Phase 2
-
Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin
RECRUITING · Phase 2
-
Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer
ACTIVE NOT RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.